CN111374094B - Method for establishing non-pregnant mouse uterine infection model caused by subcutaneous administration of donkey-derived salmonella abortus - Google Patents
Method for establishing non-pregnant mouse uterine infection model caused by subcutaneous administration of donkey-derived salmonella abortus Download PDFInfo
- Publication number
- CN111374094B CN111374094B CN202010137564.5A CN202010137564A CN111374094B CN 111374094 B CN111374094 B CN 111374094B CN 202010137564 A CN202010137564 A CN 202010137564A CN 111374094 B CN111374094 B CN 111374094B
- Authority
- CN
- China
- Prior art keywords
- salmonella
- donkey
- abortus
- mice
- derived
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000283074 Equus asinus Species 0.000 title claims abstract description 49
- 241000607729 Salmonella enterica subsp. enterica serovar Abortus Species 0.000 title claims abstract description 48
- 238000000034 method Methods 0.000 title claims abstract description 23
- 238000007920 subcutaneous administration Methods 0.000 title claims description 13
- 208000004145 Endometritis Diseases 0.000 title description 4
- 206010062233 Uterine infection Diseases 0.000 title description 4
- 241000699670 Mus sp. Species 0.000 claims abstract description 54
- 208000015181 infectious disease Diseases 0.000 claims abstract description 32
- 241000283073 Equus caballus Species 0.000 claims abstract description 28
- 210000004291 uterus Anatomy 0.000 claims abstract description 26
- 241000699666 Mus <mouse, genus> Species 0.000 claims abstract description 25
- 238000011081 inoculation Methods 0.000 claims abstract description 5
- 241000607142 Salmonella Species 0.000 claims description 35
- 230000001580 bacterial effect Effects 0.000 claims description 26
- 210000000952 spleen Anatomy 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 16
- 210000004369 blood Anatomy 0.000 claims description 10
- 239000008280 blood Substances 0.000 claims description 10
- 241000894006 Bacteria Species 0.000 claims description 9
- 108700039887 Essential Genes Proteins 0.000 claims description 9
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 claims description 8
- 239000007787 solid Substances 0.000 claims description 8
- 229920001817 Agar Polymers 0.000 claims description 6
- 239000008272 agar Substances 0.000 claims description 6
- 206010000210 abortion Diseases 0.000 claims description 5
- 231100000176 abortion Toxicity 0.000 claims description 5
- 101100216993 Bacillus subtilis (strain 168) aroD gene Proteins 0.000 claims description 4
- 101100450422 Clostridium perfringens (strain 13 / Type A) hemC gene Proteins 0.000 claims description 4
- 101100453819 Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) kgd gene Proteins 0.000 claims description 4
- 101100124346 Photorhabdus laumondii subsp. laumondii (strain DSM 15139 / CIP 105565 / TT01) hisCD gene Proteins 0.000 claims description 4
- 101150042732 aroC gene Proteins 0.000 claims description 4
- 101150104165 dnaN gene Proteins 0.000 claims description 4
- 101150050618 hemD gene Proteins 0.000 claims description 4
- 101150113423 hisD gene Proteins 0.000 claims description 4
- 101150063051 hom gene Proteins 0.000 claims description 4
- 101150111745 sucA gene Proteins 0.000 claims description 4
- 101150014006 thrA gene Proteins 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 229920000742 Cotton Polymers 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000003146 anticoagulant agent Substances 0.000 claims description 3
- 229940127219 anticoagulant drug Drugs 0.000 claims description 3
- 230000002489 hematologic effect Effects 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- -1 purE Proteins 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 230000003321 amplification Effects 0.000 claims description 2
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 claims description 2
- 230000015271 coagulation Effects 0.000 claims 1
- 238000005345 coagulation Methods 0.000 claims 1
- 238000010171 animal model Methods 0.000 abstract description 11
- 238000005516 engineering process Methods 0.000 abstract description 4
- 230000002265 prevention Effects 0.000 abstract description 3
- 230000003950 pathogenic mechanism Effects 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 13
- 238000011529 RT qPCR Methods 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 230000014509 gene expression Effects 0.000 description 7
- 210000000440 neutrophil Anatomy 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 241000607662 Salmonella enterica subsp. enterica serovar Abortusequi Species 0.000 description 5
- 230000001575 pathological effect Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 4
- 210000002808 connective tissue Anatomy 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 230000008595 infiltration Effects 0.000 description 4
- 238000001764 infiltration Methods 0.000 description 4
- 210000000754 myometrium Anatomy 0.000 description 4
- 101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 description 3
- 238000011887 Necropsy Methods 0.000 description 3
- 206010039438 Salmonella Infections Diseases 0.000 description 3
- 102100039360 Toll-like receptor 4 Human genes 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000036732 histological change Effects 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 231100000915 pathological change Toxicity 0.000 description 3
- 230000036285 pathological change Effects 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 206010039447 salmonellosis Diseases 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 102100034343 Integrase Human genes 0.000 description 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
- 230000010100 anticoagulation Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000009534 blood test Methods 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 231100000673 dose–response relationship Toxicity 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002357 endometrial effect Effects 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- GBWARTHIRIVTNI-PJHQGUKWSA-N (2s)-2,6-diaminohexanoic acid;(2r,3s,4r)-2,3,4,5-tetrahydroxypentanal Chemical compound NCCCC[C@H](N)C(O)=O.OC[C@@H](O)[C@H](O)[C@@H](O)C=O GBWARTHIRIVTNI-PJHQGUKWSA-N 0.000 description 1
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 101150071146 COX2 gene Proteins 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102100037850 Interferon gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 108090001007 Interleukin-8 Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 101150082427 Tlr4 gene Proteins 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 229940009976 deoxycholate Drugs 0.000 description 1
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005485 electric heating Methods 0.000 description 1
- 210000004696 endometrium Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/12—Animals modified by administration of exogenous cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0337—Animal models for infectious diseases
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Environmental Sciences (AREA)
- Cell Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明属于生物技术领域,具体涉及驴源马流产沙门氏菌经皮下致非妊娠期小鼠子宫感染模型的建立方法,包括以下步骤:选取清洁级ICR非妊娠期小鼠,分为空白处理组和驴源马流产沙门氏菌处理组,饲养于常规环境中,消毒小鼠背部,驴源马流产沙门氏菌处理组背部皮下接种驴源马流产沙门氏菌菌液,空白对照组皮下接种PBS。该方法改进了接种方式,缩短了感染周期,降低了实验成本,为进一步探究驴源马流产沙门氏菌的致病机理和防控技术,提供动物模型。
The invention belongs to the field of biotechnology, and in particular relates to a method for establishing a non-pregnant mouse uterus infection model caused by subcutaneously induced Salmonella abortus from donkeys. The equine-derived Salmonella abortus treatment group was raised in a conventional environment, and the backs of the mice were disinfected. The donkey-derived equine Salmonella abortus treatment group was subcutaneously inoculated with donkey-derived equine Salmonella abortus solution, and the blank control group was subcutaneously inoculated with PBS. The method improves the inoculation method, shortens the infection cycle, and reduces the experimental cost, and provides an animal model for further exploring the pathogenic mechanism and prevention and control technology of donkey-derived Salmonella abortus.
Description
技术领域technical field
本发明属于生物技术领域,具体涉及驴源马流产沙门氏菌经皮下致非妊娠期小鼠子宫感染模型的建立方法。The invention belongs to the field of biotechnology, and in particular relates to a method for establishing a non-pregnant mouse uterus infection model caused by subcutaneous Salmonella abortus from donkey origin.
背景技术Background technique
马流产沙门氏菌是导致马属动物妊娠期流产的重要传染病。研究表明,非阴道途径的子宫感染是该病原感染的重要途径之一。随着中国驴产业的发展,驴源马流产沙门氏菌导致驴流产的发生逐渐增多,但症状与马流产沙门氏菌感染有一定的差异,其感染具体机制不明确,其是否能够导致非妊娠期动物感染,从而引发配种失败或者妊娠期流产等,这都需要建立驴源沙门氏菌感染的非妊娠期动物模型进行相关研究。Salmonella abortus is an important infectious disease causing abortion in equines during pregnancy. Studies have shown that non-vaginal uterine infection is one of the important ways of this pathogenic infection. With the development of China's donkey industry, the occurrence of donkey abortions caused by Salmonella abortus from donkeys has gradually increased, but the symptoms are different from those of Salmonella abortus infection in horses. As a result, breeding failure or gestational miscarriage may be caused, which requires the establishment of a non-pregnant animal model of Salmonella infection from donkeys for related research.
发明内容SUMMARY OF THE INVENTION
本发明提供驴源马流产沙门氏菌经皮下致非妊娠期小鼠子宫感染模型的建立方法,该方法改进了接种方式,缩短了感染周期,降低了实验成本,为进一步探究驴源马流产沙门氏菌的致病机理和防控技术,提供动物模型。The invention provides a method for establishing a non-pregnant mouse uterus infection model caused by subcutaneous Salmonella abortus from donkey origin. Pathogenesis and prevention and control technology, animal models are provided.
为达到上述目的,本发明提供了如下技术方案:To achieve the above object, the invention provides the following technical solutions:
驴源马流产沙门氏菌经皮下致非妊娠期小鼠子宫感染模型的建立方法,包括以下步骤:A method for establishing a non-pregnant mouse uterus infection model by subcutaneous Salmonella abortus from donkey origin includes the following steps:
选取清洁级ICR非妊娠期小鼠,分为空白处理组和驴源马流产沙门氏菌处理组,饲养于常规环境中,消毒小鼠背部,驴源马流产沙门氏菌处理组背部皮下接种驴源马流产沙门氏菌菌液,空白对照组皮下接种PBS。Clean-grade ICR non-pregnant mice were selected and divided into a blank treatment group and a donkey-derived equine Salmonella abortus treatment group. They were raised in a conventional environment and the backs of the mice were disinfected. The donkey-derived equine Salmonella abortus treatment group was subcutaneously inoculated with donkey-derived equine abortus Salmonella on the back. Bacterial liquid, blank control group was subcutaneously inoculated with PBS.
进一步的,所述驴源马流产沙门氏菌处理组分为驴源马流产沙门氏菌处理组Ⅰ和驴源马流产沙门氏菌处理组Ⅱ,分别皮下接种0.1mL 109cfu/mL驴源马流产沙门氏菌液和0.1mL 1011cfu/mL驴源马流产沙门氏菌液。Further, said donkey-derived equine aborted Salmonella treatment components are donkey-derived equine aborted Salmonella treatment group I and donkey-derived equine aborted Salmonella treatment group II, respectively subcutaneously inoculated with 0.1 mL of 10 9 cfu/mL donkey-derived equine aborted Salmonella solution and 0.1
进一步的,接种后,在小鼠感染后第8天,脱颈处死小鼠。Further, after the inoculation, on the 8th day after the mice were infected, the mice were sacrificed by cervical dislocation.
进一步的,所述小鼠为8-10周龄。Further, the mice are 8-10 weeks old.
进一步的,所述小鼠饲养于常规环境中适应一周,自由饮水和进食,光照与黑暗为12h交替。Further, the mice were reared in a conventional environment for a week to acclimate, with free access to water and food, and the light and dark were alternated for 12 hours.
进一步的,所述消毒方法为棉签蘸取75%酒精消毒小鼠背部。Further, the disinfection method is to dip a cotton swab in 75% alcohol to disinfect the back of the mouse.
进一步的,所述驴源马流产沙门氏菌液制备方法为:取冷冻保存的驴源马流产沙门氏菌液,充分摇匀,接种于LB固体培养基上,置于37℃恒温培养箱培养15h,无菌挑取驴源马流产沙门氏菌的单个菌落接种于LB液体培养基,120r/m,37℃条件下培养6h,取适量菌液,4000rpm,5min,弃上清,PBS冲洗菌体和均质菌液,将其调整为109cfu/mL和1011cfu/mL。Further, the preparation method of the donkey-derived equine aborted Salmonella liquid is as follows: take the frozen-preserved donkey-derived equine aborted Salmonella liquid, shake it well, inoculate it on LB solid medium, and place it in a 37°C constant temperature incubator for 15 hours, sterile. Pick a single colony of donkey-derived Salmonella abortus and inoculate it in LB liquid medium, culture at 120r/m, 37°C for 6h, take an appropriate amount of bacterial solution, 4000rpm, 5min, discard the supernatant, rinse the bacterial cells and homogeneous bacterial solution with PBS , adjusted to 10 9 cfu/mL and 10 11 cfu/mL.
进一步的,在小鼠感染后第8天,小鼠眼球摘除采血200μL至抗凝管中,轻弹管壁,便于抗凝剂与血液混匀,随即进行血液学指标检查。Further, on the 8th day after the mice were infected, the mice were enucleated and 200 μL of blood was collected into the anticoagulation tube, and the wall of the tube was flicked to facilitate the mixing of the anticoagulant and the blood, and then the hematological index was checked.
进一步的,在小鼠感染后第8天,脱颈处死小鼠,无菌采集其脾脏和子宫样品接种于LB固体培养基,置于37℃恒温培养箱培养12-15h,再挑取单个菌落接种至XLD琼脂,置于37℃恒温培养箱培养15-18h;挑取单个待检菌落,进行细菌的MALDI Biotyper系统鉴定。Further, on the 8th day after the mice were infected, the mice were sacrificed by cervical dislocation, and the spleen and uterus samples were collected aseptically and inoculated into LB solid medium, placed in a 37°C constant temperature incubator for 12-15 hours, and then a single colony was picked. It was inoculated into XLD agar and placed in a constant temperature incubator at 37°C for 15-18 hours; a single colony to be tested was picked and identified by the MALDI Biotyper system.
进一步的,提取沙门氏菌的全基因组DNA进行PCT扩增,对沙门氏菌进行MLST分型,用于沙门氏菌MLST分型的7个管家基因为aroC、dnaN、hisD、thrA、purE、hemD和sucA,管家基因引物序列如下:Further, the whole genome DNA of Salmonella was extracted for PCT amplification, and MLST was performed on Salmonella. The 7 housekeeping genes used for MLST typing of Salmonella were aroC, dnaN, hisD, thrA, purE, hemD and sucA, housekeeping gene primers. The sequence is as follows:
本发明提供的技术方案实现了以下有益效果:The technical scheme provided by the present invention has achieved the following beneficial effects:
1.应激小、操作简便:本发明选择小鼠背部皮下接种细菌,感染部位准确且易于操作,对小鼠应激程度低。2.饲养方便、成本较低:本发明选择低成本、易购买的ICR小鼠作为实验动物,饲养于常规环境中,便于管理,且实验结果贴合临床实际。3.感染期短、感染率高:皮下接种后,仅需8天感染期,即可造成非妊娠期小鼠子宫细菌感染和炎症。4.首次采用驴源沙门氏菌建立经皮下途径感染子宫模型,也证实了非阴道途径也是造成子宫感染的途径之一。5.提供了替代大动物作为实验动物的实验动物模型,增加了动物实验的可行性。6.临床意义重大:通过本发明中的非妊娠期小鼠模型可探究驴源性马流产沙门氏菌的子宫感染所致的流产、配种失败等机制,为科学研究提供动物模型。1. Less stress and easy operation: the present invention selects mice to inoculate bacteria subcutaneously on the back of the mice, the infection site is accurate and easy to operate, and the degree of stress to the mice is low. 2. Convenient feeding and low cost: the present invention selects low-cost, easy-to-buy ICR mice as experimental animals, and is raised in a conventional environment, which is convenient for management, and the experimental results conform to clinical practice. 3. Short infection period and high infection rate: After subcutaneous inoculation, only 8 days of infection period can cause bacterial infection and inflammation of the uterus of non-pregnant mice. 4. For the first time, the model of subcutaneous infection of uterus was established by Salmonella from donkey, and it was also confirmed that non-vaginal route was also one of the ways to cause uterine infection. 5. Provides an experimental animal model that replaces large animals as experimental animals, increasing the feasibility of animal experiments. 6. Significant clinical significance: The non-pregnant mouse model in the present invention can explore mechanisms such as abortion and breeding failure caused by uterine infection of donkey-derived Salmonella abortus, providing animal models for scientific research.
附图说明Description of drawings
图1为小鼠临床症状与剖检变化结果;Figure 1 shows the results of clinical symptoms and necropsy changes in mice;
图2为小鼠血常规结果;Figure 2 shows the results of routine blood tests for mice;
图3为沙门氏菌质谱图;Fig. 3 is Salmonella mass spectrum;
图4为Biotyper匹配结果;Figure 4 is the Biotyper matching result;
图5为沙门氏菌MLST管家基因PCR扩增图;Fig. 5 is the PCR amplification diagram of Salmonella MLST housekeeping gene;
图6为沙门氏菌ST型比对结果;Fig. 6 is the comparison result of Salmonella ST type;
图7为小鼠脾脏和子宫细菌载量结果;Figure 7 shows the results of bacterial load in mouse spleen and uterus;
图8为小鼠脾脏组织学变化结果(HE);Figure 8 is the histological change results of mouse spleen (HE);
图9为小鼠子宫内膜组织学变化结果(HE);Fig. 9 is the histological change result of mouse endometrial (HE);
图10为小鼠子宫肌层及外膜组织学变化结果(HE);Figure 10 shows the histological changes of mouse myometrium and adventitia (HE);
图11为qPCR检测小鼠子宫中TLR4及炎症因子的表达结果。Figure 11 shows the results of qPCR detection of the expression of TLR4 and inflammatory factors in mouse uterus.
注:Control对照组;108/S.Abortusequi 108/马流产沙门氏菌组;1010/S.Abortusequi 1010/马流产沙门氏菌组Note: Control control group; 10 8 /S.Abortusequi 10 8 /Salmonella abortus equine group; 10 10 /S.Abortusequi 10 10 /Salmonella abortus equine group
具体实施方式Detailed ways
1材料1 material
1.1菌株1.1 Strains
驴源马流产沙门氏菌由扬州大学兽医学院兽医外科教研室分离鉴定并保存。Donkey-derived Salmonella abortus was isolated, identified and preserved by the Department of Veterinary Surgery, School of Veterinary Medicine, Yangzhou University.
1.2试验动物1.2 Experimental animals
8-10周龄清洁级ICR非妊娠期小鼠,购自扬州大学比较医学中心。8-10-week-old clean-grade ICR non-pregnant mice were purchased from the Center for Comparative Medicine, Yangzhou University.
1.3主要试剂1.3 Main reagents
胰蛋白胨和酵母提取物,由OXOID公司生产;木糖赖氨酸脱氧胆酸盐(XLD)琼脂,由杭州微生物试剂有限公司生产;琼脂粉,由北京索莱宝科技有限公司生产;TIANampBacteria DNAKit和TIANGEN TRNzol Universal,由天根生化技术有限公司生产;2×EasyTaq PCR SuperMIX和DNA Marker,由北京全式金生物技术有限公司生产;基质溶液,由德国布鲁克公司生产;HiScript Reverse Transcriptase试剂盒,由南京诺唯赞生物科技有限公司生产。Tryptone and yeast extract, produced by OXOID company; xylose lysine deoxycholate (XLD) agar, produced by Hangzhou Microbial Reagent Co., Ltd.; agar powder, produced by Beijing Soleibo Technology Co., Ltd.; TIANampBacteria DNAKit and TIANGEN TRNzol Universal, produced by Tiangen Biochemical Technology Co., Ltd.; 2×EasyTaq PCR SuperMIX and DNA Marker, produced by Beijing Quanzhijin Biotechnology Co., Ltd.; Matrix Solution, produced by Bruker, Germany; HiScript Reverse Transcriptase Kit, Nanjing Manufactured by Novozymes Biotechnology Co., Ltd.
1.4主要仪器1.4 Main instruments
PCR仪、Gel Doc XR+凝胶成像系统、荧光定量PCR仪,由美国BIO-RAD公司生产;迈瑞BC-2800动物血球分析仪,由深圳迈瑞生物医疗电子股份有限公司生产;紫外可见分光光度计,由上海光谱仪器有限公司生产;紫外分光光度计,由美国Thermo公司生产;MALDIBiotyper微生物鉴定系统,由德国布鲁克公司生产;生物显微镜(型号为Olympus CX22),由日本Olympus公司生产;多功能台式冷冻离心机,由德国eppendorf公司生产;全温培养摇床,电热恒温鼓风干燥箱,由上海精宏实验设备有限公司生产;石蜡切片机,由德国Leica公司生产。PCR instrument, Gel Doc XR+ gel imaging system, fluorescence quantitative PCR instrument, produced by BIO-RAD, USA; Mindray BC-2800 animal blood cell analyzer, produced by Shenzhen Mindray Biomedical Electronics Co., Ltd.; UV-Vis Spectrophotometer, Produced by Shanghai Spectrum Instrument Co., Ltd.; UV spectrophotometer, produced by Thermo Company of the United States; MALDI Biotyper Microbial Identification System, produced by Bruker Company of Germany; Biological microscope (model Olympus CX22), produced by Olympus Company of Japan; machine, produced by German Eppendorf company; full-temperature culture shaker, electric heating constant temperature blast drying oven, produced by Shanghai Jinghong Experimental Equipment Co., Ltd.; paraffin microtome, produced by German Leica company.
2方法2 methods
2.1菌株的复苏2.1 Recovery of strains
取冷冻保存的菌液,充分摇匀,接种于LB固体培养基上,置于37℃恒温培养箱培养15h。Take the cryopreserved bacterial liquid, shake it well, inoculate it on LB solid medium, and place it in a constant temperature incubator at 37°C for 15h.
2.2菌液的制备2.2 Preparation of bacterial solution
无菌挑取驴源马流产沙门氏菌(以下简称为马流产沙门氏菌)的单个菌落接种于LB液体培养基,120r/m,37℃条件下培养6h,取适量菌液,4000rpm,5min,弃上清,PBS冲洗菌体和均质菌液,将其调整为109cfu/mL和1011cfu/mL。Aseptically pick a single colony of donkey-derived Salmonella abortus (hereinafter referred to as Salmonella abortus), inoculate it in LB liquid medium, cultivate at 120r/m, 37°C for 6h, take an appropriate amount of bacterial liquid, 4000rpm, 5min, discard the supernatant , PBS washed the cells and the homogenized bacterial solution, and adjusted them to 10 9 cfu/mL and 10 11 cfu/mL.
2.3动物分组及感染2.3 Animal grouping and infection
18只ICR小鼠随机分为3组,即空白处理组、马流产沙门氏菌处理组Ⅰ和Ⅱ,每组6只,饲养于常规环境中,适应一周,自由饮水和进食,光照与黑暗为12h交替。棉签蘸取75%酒精消毒小鼠背部,马流产沙门氏菌处理组Ⅰ和Ⅱ分别皮下接种0.1mL菌液(109cfu/mL和1011cfu/mL),空白对照组皮下接种0.1mLPBS,接种后,连续观察至第8d,剖检小鼠。18 ICR mice were randomly divided into 3 groups, namely blank treatment group, Salmonella abortus treatment group I and II, 6 mice in each group, reared in conventional environment, acclimatized for one week, freely drinking water and food, light and dark alternated for 12 hours . A cotton swab was dipped in 75% alcohol to disinfect the back of the mice, and 0.1 mL of bacterial solution (10 9 cfu/mL and 10 11 cfu/mL) was subcutaneously inoculated in Salmonella abortus treatment groups I and II, respectively, and 0.1 mL of PBS was subcutaneously inoculated in the blank control group. , continuously observed until the 8th day, the mice were necropsied.
2.4血常规检查2.4 Routine blood test
在小鼠感染后第8天,小鼠眼球摘除采血200μL至抗凝管中,轻弹管壁,便于抗凝剂与血液混匀,随即进行血液学指标检查。On the 8th day after the mice were infected, the mice were enucleated and 200 μL of blood was collected into the anticoagulation tube, and the wall of the tube was flicked to facilitate the mixing of the anticoagulant and the blood, and then the hematological index was checked.
2.5细菌分离、培养与鉴定2.5 Bacterial isolation, culture and identification
2.5.1细菌分离、培养2.5.1 Bacterial isolation and culture
在小鼠感染后第8天,脱颈处死小鼠,无菌采集脾脏和子宫样品接种于LB固体培养基,置于37℃恒温培养箱培养12-15h,再挑取单个菌落接种至XLD琼脂,置于37℃恒温培养箱培养15-18h。On the 8th day after the mice were infected, the mice were sacrificed by cervical dislocation, the spleen and uterus samples were collected aseptically and inoculated into LB solid medium, placed in a constant temperature incubator at 37°C for 12-15 hours, and then a single colony was picked and inoculated into XLD agar , placed in a constant temperature incubator at 37°C for 15-18h.
2.5.2细菌的MALDI Biotyper系统鉴定2.5.2 MALDI Biotyper System Identification of Bacteria
挑取单个待检菌落,涂于MALDI靶板上,自然干燥;加入1μL的70%的甲酸覆盖菌落涂层,自然干燥;随后加基质溶液1μL覆盖,自然干燥。将靶板放于质谱仪中检测。FlexControl和MALDI Biotyper RTC采集特异性图谱,通过与Biotyper数据库参考图谱进行匹配,进行细菌鉴定,当Bruker Biotyper分值≥2.0时,认为结果高度可信。Pick a single colony to be tested, spread it on the MALDI target plate, and dry naturally; add 1 μL of 70% formic acid to cover the colony coating and dry naturally; then add 1 μL of matrix solution to cover and dry naturally. The target plate is placed in the mass spectrometer for detection. FlexControl and MALDI Biotyper RTC collect specific maps, and perform bacterial identification by matching with the reference maps of the Biotyper database. When the Bruker Biotyper score is ≥ 2.0, the result is considered to be highly credible.
2.5.3沙门氏菌的MLST分型2.5.3 MLST typing of Salmonella
2.5.3.1沙门氏菌DNA提取2.5.3.1 Salmonella DNA extraction
挑取沙门氏菌单个菌落接种于LB液体培养基,37℃,120r/m培养18-24h后,以制备好的细菌培养液为样品,按照TIANamp Bacteria DNA Kit试剂盒说明书提取沙门氏菌的全基因组DNA,用做PCR模板。Pick a single colony of Salmonella and inoculate it in LB liquid medium. After culturing for 18-24 hours at 37°C and 120r/m, take the prepared bacterial culture solution as a sample and extract the whole genome DNA of Salmonella according to the instructions of the TIANamp Bacteria DNA Kit. Make PCR template.
2.5.3.2引物设计与合成2.5.3.2 Primer Design and Synthesis
用于沙门氏菌MLST分型的7个管家基因为aroC、dnaN、hisD、thrA、purE、hemD和sucA,管家基因引物序列见表1。The seven housekeeping genes used for MLST typing of Salmonella are aroC, dnaN, hisD, thrA, purE, hemD and sucA. The primer sequences of the housekeeping genes are shown in Table 1.
表1 MLST管家基因引物序列Table 1 MLST housekeeping gene primer sequences
2.5.3.3PCR反应程序2.5.3.3 PCR reaction program
PCR反应总体系为25μL:2×EasyTaq PCR SuperMIX 12.5μL,上下游引物(10μM)各1μL,模板DNA2μL,补充RNase-free水至25μL。PCR反应程序为预变性温度94℃,时间3min;变性温度94℃,时间30s;退火温度55℃,时间30s;延伸温度72℃,时间1min;30个循环,最后72℃延伸5min。反应结束后,取5μL PCR反应原液于1%琼脂糖凝胶电泳,电压120V,时间30min,于Gel Doc XR+凝胶成像系统观察结果。将PCR阳性反应产物送至南京擎科生物技术有限公司测序,用MEGA5.0进行编辑处理序列结果,将得到的各序列上传MLST网站,获取每个菌株等位基因的编号,进而确定每个菌株的ST型别。The total PCR reaction system is 25 μL: 12.5 μL of 2×EasyTaq PCR SuperMIX, 1 μL of upstream and downstream primers (10 μM), 2 μL of template DNA, and supplemented with RNase-free water to 25 μL. The PCR reaction program was as follows: pre-denaturation temperature 94 °C, time 3 min; denaturation temperature 94 °C, time 30 s; annealing temperature 55 °C, time 30 s; extension temperature 72 °C, time 1 min; 30 cycles, and a final extension at 72 °C for 5 min. After the reaction, 5 μL of the PCR reaction stock solution was taken and electrophoresed on a 1% agarose gel at a voltage of 120 V for 30 min, and the results were observed on a Gel Doc XR+ gel imaging system. The PCR positive reaction product was sent to Nanjing Qingke Biotechnology Co., Ltd. for sequencing, and MEGA5.0 was used to edit and process the sequence results. The obtained sequences were uploaded to the MLST website to obtain the allele number of each strain, and then determine each strain. The ST type.
2.6平板菌落计数测定组织细菌载量2.6 Determination of tissue bacterial load by plate colony counting
小鼠于感染后第8天脱颈处死,采集小鼠的部分脾脏和子宫组织,称重,添加适量PBS,研钵将其研磨至组织匀浆,将组织匀浆作10倍梯度稀释,选取合适稀释浓度的10μL菌液接种于LB固体培养基上,每个梯度做三次重复,取平均值,37℃恒温静置培养15-18h,计数,按公式计算,组织细菌载量计算公式为 Mice were sacrificed by cervical dislocation on the 8th day after infection. Part of the spleen and uterine tissues of the mice were collected, weighed, added with an appropriate amount of PBS, and ground into tissue homogenate with a mortar. 10 μL of bacterial solution with appropriate dilution concentration was inoculated on LB solid medium, each gradient was repeated three times, the average value was taken, and the bacteria were cultured at a constant temperature of 37 °C for 15-18 h, counted, and calculated according to the formula. The formula for calculating the bacterial load of the tissue is:
n:平板菌落数;m:匀浆组织的重量(单位:g);r:稀释倍数;结果以对数(log10)形式表示。n: the number of colonies on the plate; m: the weight of the homogenized tissue (unit: g); r: the dilution ratio; the results are expressed in the form of logarithm (log 10 ).
2.7病理学观察2.7 Pathological observation
采集小鼠的脾脏和子宫于10%福尔马林溶液中固定,制作切片,采用HE染色,进行病理组织学观察。The spleen and uterus of the mice were collected, fixed in 10% formalin solution, sliced, and stained with HE for histopathological observation.
2.8 qPCR检测TLR4及炎症因子的表达2.8 qPCR to detect the expression of TLR4 and inflammatory factors
2.8.1样品采集2.8.1 Sample Collection
采集小鼠子宫组织至冻存管,液氮速冻,转入-80℃冰箱保存。The mouse uterine tissue was collected into cryopreservation tubes, quick-frozen in liquid nitrogen, and transferred to a -80°C refrigerator for storage.
2.8.2子宫组织RNA提取与反转录2.8.2 Uterine tissue RNA extraction and reverse transcription
按照TIANGEN TRNzol Universal及HiScript Reverse Transcriptase试剂盒说明书提取子宫组织中RNA继而反转录成cDNA,用做qPCR模板。According to the instructions of TIANGEN TRNzol Universal and HiScript Reverse Transcriptase kits, RNA was extracted from uterine tissue and then reverse transcribed into cDNA, which was used as qPCR template.
2.8.3引物设计与合成2.8.3 Primer Design and Synthesis
根据参考文献中报道的引物序列,共设计扩增9种qPCR引物,由南京擎科生物技术有限公司合成,引物序列见表2。According to the primer sequences reported in the reference, a total of 9 qPCR primers were designed and amplified, which were synthesized by Nanjing Qingke Biotechnology Co., Ltd. The primer sequences are shown in Table 2.
表2目的基因引物序列Table 2 Target gene primer sequences
2.8.4 qPCR反应程序2.8.4 qPCR reaction program
qPCR反应总体系为10μL:SYBR qPCR Master MIX 5μL,上下游引物(10μM)各1μL,模板cDNA 2μL,补充RNase-free水至10μL。PCR反应程序为95℃、30s;95℃、5s,60℃、30s后循环40次;95℃、15s;60℃、1min;95℃、15s后37℃保存。The total qPCR reaction system is 10 μL: 5 μL of SYBR qPCR Master MIX, 1 μL of upstream and downstream primers (10 μM), 2 μL of template cDNA, and supplemented with RNase-free water to 10 μL. The PCR reaction program was 95°C, 30s; 95°C, 5s, 60°C, 30s followed by 40 cycles; 95°C, 15s; 60°C, 1 min; 95°C, 15s and then stored at 37°C.
2.8.5数据分析2.8.5 Data Analysis
采用2-△△Ct法计算各基因的表达量,数据采用SPSS软件中的One-Way ANOVA进行统计分析,结果以Mean±SEM的形式表示。p<0.05表示差异显著,p<0.01表示差异极显著。The 2- △△Ct method was used to calculate the expression of each gene, and the data were statistically analyzed by One-Way ANOVA in SPSS software, and the results were expressed in the form of Mean±SEM. p<0.05 means significant difference, p<0.01 means extremely significant difference.
3结果3 results
3.1临床症状与剖检变化结果3.1 Clinical symptoms and necropsy changes
与空白对照组相比,马流产沙门氏菌处理组Ⅰ和Ⅱ小鼠均出现明显被毛杂乱(图1A);马流产沙门氏菌处理组Ⅱ小鼠食欲减弱现象严重,不愿走动,感染第5d,个别小鼠发生死亡;感染第8d,剖检可见马流产沙门氏菌处理组Ⅰ和Ⅱ小鼠脾脏肿大和出血明显(图1B),子宫角长度明显缩短(图1C)Compared with the blank control group, mice in Salmonella abortus equi-treated group I and II had obvious hair disorganization (Fig. 1A). Mice in Salmonella abortus equi-treated group II had severe appetite loss and were reluctant to walk. On the 5th day of infection, some The mice died; on the 8th day of infection, the necropsy showed that the spleen enlargement and hemorrhage were obvious in the Salmonella abortus-treated group I and II (Fig. 1B), and the length of the uterine horn was significantly shortened (Fig. 1C).
3.2血常规结果3.2 Blood routine results
由图2A和B所示,马流产沙门氏菌处理组Ⅰ和Ⅱ小鼠血液中白细胞数和中性粒细胞数与空白对照组相比均显著升高(p<0.05),且超过生理正常值范围;处理组Ⅱ小鼠血液中白细胞数和中性粒细胞数较处理组Ⅰ升高,但统计学差异不显著(p>0.05);与空白处理组相比,马流产沙门氏菌处理组Ⅰ和Ⅱ小鼠血液中淋巴细胞数升高,但无统计学差异,未表现出剂量依赖性。As shown in Figure 2A and B, the number of white blood cells and neutrophils in the blood of the mice treated with Salmonella abortus equi I and II were significantly increased compared with the blank control group (p<0.05), and exceeded the range of physiological normal values. ; The number of leukocytes and neutrophils in the blood of mice in treatment group II were higher than those in treatment group I, but the difference was not statistically significant (p>0.05); The number of lymphocytes in the blood of the mice increased, but there was no statistical difference, and it did not show a dose-dependence.
3.3.1细菌分离和培养结果3.3.1 Bacterial isolation and culture results
空白对照组小鼠的脾脏和子宫样品均没有细菌生长;马流产沙门氏菌处理组Ⅰ和Ⅱ小鼠脾脏和子宫分离出的细菌在LB固体培养基上呈圆形、透明菌落,在XLD琼脂平板上呈圆形粉红色、硫化氢和乳糖阴性的菌落。There was no bacterial growth in the spleen and uterus samples of the mice in the blank control group; the bacteria isolated from the spleen and uterus of the mice in the Salmonella abortus treatment group I and II were round and transparent colonies on LB solid medium and on XLD agar plates. Colonies are round pink and negative for hydrogen sulfide and lactose.
3.3.2细菌的MALDI Biotyper系统鉴定结果3.3.2 MALDI Biotyper system identification results of bacteria
依据Flex Control和MALDI Biotyper RTC采集特异性图谱与Biotyper数据库匹配的结果,鉴定分离菌为沙门氏菌,质谱图及Biotyper匹配结果见图3、4和表3。According to the matching results between Flex Control and MALDI Biotyper RTC collection-specific maps and the Biotyper database, the isolated bacteria were identified as Salmonella. The mass spectrum and Biotyper matching results are shown in Figures 3, 4 and Table 3.
表3 Biotyper匹配结果Table 3 Biotyper matching results
3.3.3 MLST分子分型结果3.3.3 MLST molecular typing results
如图5、6和表4所示,分离菌能扩增出沙门氏菌7个管家基因,ST型为马流产沙门氏菌ST251。As shown in Figures 5, 6 and Table 4, the isolated bacteria can amplify 7 housekeeping genes of Salmonella, and the ST type is Salmonella abortus ST251.
表4沙门氏菌ST型比对结果Table 4 Salmonella ST type comparison results
3.4细菌载量结果3.4 Bacterial load results
感染第8天对各组小鼠脾脏和子宫进行马流产沙门氏菌计数,脾脏和子宫细菌载量如图7所示。空白对照组小鼠脾脏和子宫未检测到马流产沙门氏菌;马流产沙门氏菌处理组Ⅱ小鼠脾脏和子宫的细菌载量较沙门氏菌处理组Ⅰ高,表现出剂量依赖性。The spleen and uterus of mice in each group were counted for Salmonella equivarius on the 8th day of infection, and the bacterial loads in the spleen and uterus were shown in Figure 7. No Salmonella abortus was detected in the spleen and uterus of the mice in the blank control group; the bacterial loads in the spleen and uterus of the mice in the Salmonella abortus treatment group II were higher than those in the Salmonella abortus treatment group I, showing a dose-dependent manner.
3.5病理学观察结果3.5 Pathological observations
3.5.1脾脏病理学观察结果3.5.1 Pathological observation results of spleen
由图8A和B可知,空白对照组小鼠脾结构完整,白髓与红髓界限清晰,异常病理学变化。马流产沙门氏菌处理组Ⅰ和Ⅱ小鼠的脾脏中白髓向红髓增生扩展明显、动脉周围淋巴鞘结构改变、面积增大和淋巴细胞聚集区扩大,红髓中红细胞明显增多,脾脏出血(图8C、D、E和F)。As can be seen from Figure 8A and B, the spleen structure of the mice in the blank control group was complete, the boundary between the white pulp and the red pulp was clear, and there were abnormal pathological changes. In the spleen of Salmonella abortus equine-treated group I and II mice, the proliferation of white pulp to red pulp was obvious, the structure of periarterial lymphatic sheath was changed, the area was enlarged, and the area of lymphocyte aggregation was enlarged, red blood cells in red pulp were significantly increased, and spleen hemorrhage (Fig. 8C). , D, E and F).
3.5.2子宫内膜病理学观察结果3.5.2 Endometrial pathological observation results
由图9A和B可知,空白对照组小鼠子宫内膜(即上皮及基质层)结构完整,无异常病理变化。如图9C、D、E和F所示,马流产沙门氏菌处理组Ⅰ和Ⅱ小鼠子宫上皮及基质层结构完整;基质层内子宫腺出现嗜中性粒细胞浸润;处理组Ⅱ子宫腺管中嗜中性粒细胞浸润明显多于处理组Ⅰ。It can be seen from Figures 9A and B that the endometrium (ie, the epithelium and the stromal layer) of the mice in the blank control group has a complete structure and no abnormal pathological changes. As shown in Figure 9C, D, E and F, the structure of the uterine epithelium and stromal layer of the mice in Salmonella abortus equina-treated group I and II was intact; neutrophil infiltration appeared in the uterine glands in the stromal layer; Neutrophil infiltration was significantly more than that in treatment group Ⅰ.
3.5.3子宫肌层及外膜病理学观察结果3.5.3 Pathological observation results of myometrium and adventitia
由图10A和B可知,空白对照组小鼠子宫肌层及外膜层结构完整,有少量嗜中性粒细胞浸润,无异常病理变化。如图10C、D、E和F所示,马流产沙门氏菌处理组Ⅰ和Ⅱ小鼠子宫肌层及外膜层结构完整;与处理组Ⅱ相比,处理组Ⅰ小鼠的子宫肌层及外膜层中嗜中性粒细胞浸润明显增多。It can be seen from Figure 10A and B that the structure of the myometrium and adventitia layer of the mice in the blank control group was complete, with a small amount of neutrophil infiltration, and no abnormal pathological changes. As shown in Figure 10C, D, E and F, the structure of the myometrium and adventitia of the mice in Salmonella abortus equina-treated group I and II were intact; Neutrophil infiltration was significantly increased in the membrane layer.
3.6qPCR检测TLR4及炎症因子的表达结果3.6 The expression results of TLR4 and inflammatory factors detected by qPCR
如图11A所示,与空白对照组相比,不同浓度马流产沙门氏菌感染后TLR4基因表达水平显著升高(p<0.01),且呈浓度依赖性。由图11B、C、D、E、F和G可知,马流产沙门氏菌处理组Ⅰ和Ⅱ的促炎因子IL-1β、趋化因子(IL-6和IL-8)、Th1型细胞因子(TNF-α和IFN-γ)、Th2型细胞因子(IL-10)的基因表达水平较空白组显著升高(p<0.05),但未呈浓度依赖性,例如,马流产沙门氏菌处理组Ⅱ的IFN-γ基因水平显著低于处理组Ⅰ(p<0.05)。与空白对照组相比,马流产沙门氏菌感染后COX-2基因表达水平表现剂量依赖性升高(图11H),高浓度马流产沙门氏菌处理组Ⅱ较空白处理组差异显著(p<0.01)。As shown in Figure 11A, compared with the blank control group, the expression level of TLR4 gene was significantly increased (p<0.01) after infection with different concentrations of Salmonella abortus in a concentration-dependent manner. From Figure 11B, C, D, E, F and G, it can be seen that the pro-inflammatory factor IL-1β, chemokine (IL-6 and IL-8), Th1-type cytokine (TNF-α) in Salmonella abortus treatment groups I and II -α and IFN-γ) and Th2-type cytokine (IL-10) gene expression levels were significantly higher than those in the blank group (p<0.05), but not in a concentration-dependent manner. For example, IFN in Salmonella abortus treatment group II The level of -γ gene was significantly lower than that of treatment group I (p<0.05). Compared with the blank control group, the expression level of COX-2 gene increased in a dose-dependent manner after S. abortus infection (Fig. 11H), and the high-concentration S. abortus treatment group II was significantly different from the blank treatment group (p<0.01).
本技术发明采用驴源沙门氏菌感染常见的动物模型,即ICR非妊娠期小鼠,建立动物感染模型,并通过血常规、组织细菌载量的平板计数、组织病理学和相关炎症基因表达等先进的方法检测方法,建立驴源沙门氏菌感染非妊娠期小鼠的动物模型。该模型的成功建立,改进了接种方式,缩短了感染周期,降低了实验成本,为进一步探究驴源马流产沙门氏菌的致病机理和防控技术,提供动物模型。The technology of the present invention adopts the common animal model of Salmonella infection from donkeys, namely ICR non-pregnant mice, to establish an animal infection model. Methods Detection methods: An animal model of donkey-derived Salmonella infection in non-pregnant mice was established. The successful establishment of this model improves the inoculation method, shortens the infection cycle, and reduces the experimental cost. It provides an animal model for further exploration of the pathogenic mechanism and prevention and control technology of Salmonella abortus from donkeys.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010137564.5A CN111374094B (en) | 2020-03-02 | 2020-03-02 | Method for establishing non-pregnant mouse uterine infection model caused by subcutaneous administration of donkey-derived salmonella abortus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010137564.5A CN111374094B (en) | 2020-03-02 | 2020-03-02 | Method for establishing non-pregnant mouse uterine infection model caused by subcutaneous administration of donkey-derived salmonella abortus |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111374094A CN111374094A (en) | 2020-07-07 |
CN111374094B true CN111374094B (en) | 2022-04-19 |
Family
ID=71213583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010137564.5A Active CN111374094B (en) | 2020-03-02 | 2020-03-02 | Method for establishing non-pregnant mouse uterine infection model caused by subcutaneous administration of donkey-derived salmonella abortus |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111374094B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108220183A (en) * | 2016-12-22 | 2018-06-29 | 新疆农业大学 | One plant of Salmonella abortus equi bacterial strain SMXJ-97 and its application in Salmonella abortus equi vaccine |
CN110511889A (en) * | 2019-08-20 | 2019-11-29 | 山东省农业科学院畜牧兽医研究所 | Salmonella AD19 plants of one plant of donkey source and its application |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE269104T1 (en) * | 1999-12-28 | 2004-07-15 | Akzo Nobel Nv | SALMONELLA VACCINE THAT DOES NOT INDUCE ANTIBODIES TO FLAGELLIN OR TO FLAGELLA |
-
2020
- 2020-03-02 CN CN202010137564.5A patent/CN111374094B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108220183A (en) * | 2016-12-22 | 2018-06-29 | 新疆农业大学 | One plant of Salmonella abortus equi bacterial strain SMXJ-97 and its application in Salmonella abortus equi vaccine |
CN110511889A (en) * | 2019-08-20 | 2019-11-29 | 山东省农业科学院畜牧兽医研究所 | Salmonella AD19 plants of one plant of donkey source and its application |
Non-Patent Citations (2)
Title |
---|
马沙门氏菌病的流行与诊治方法;王欣;《现代畜牧科技》;20171231(第04期);第129页 * |
马流产沙门氏杆菌C系弱毒菌苗的研究;童昆周等;《中国农业科学》;19801231(第01期);第80-89页 * |
Also Published As
Publication number | Publication date |
---|---|
CN111374094A (en) | 2020-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhu et al. | Bacterial communities in the womb during healthy pregnancy | |
CN107164482B (en) | A method for detecting insertion/deletion of goat CSN1S1 gene and its application | |
CN115820921B (en) | Primer probe combination for detecting three lung invasive fungi and digital PCR kit thereof | |
CN113502354A (en) | Pathogen detection primer and probe set for transplanted patient infection, kit and application | |
Marino et al. | Johne’s disease in cattle: an in vitro model to study early response to infection of Mycobacterium avium subsp. paratuberculosis using RNA-seq. | |
Abarca et al. | Cutaneous hyalohyphomycosis caused by a Chrysosporium species related to Nannizziopsis vriesii in two green iguanas (Iguana iguana) | |
Amato et al. | A case of bovine trypanosomiasis caused by Trypanosoma theileri in Sicily, Italy | |
Baumbach et al. | Identification of zoophilic dermatophytes using MALDI-TOF mass spectrometry | |
Chen et al. | Multiple lines of evidence on the genetic relatedness of the parthenogenetic and bisexual Haemaphysalis longicornis (Acari: Ixodidae) | |
Clinton et al. | Molecular identification of potential aquaculture pathogens adherent to cnidarian zooplankton | |
Awandkar et al. | Novel fluconazole-resistant zoonotic yeast isolated from mastitis | |
Hestvik et al. | Tularaemia in European brown hares (Lepus europaeus) and mountain hares (Lepus timidus) characterized by histopathology and immunohistochemistry: organ lesions and suggestions of routes of infection and shedding | |
CN111374094B (en) | Method for establishing non-pregnant mouse uterine infection model caused by subcutaneous administration of donkey-derived salmonella abortus | |
Tsang et al. | Hepatic phaeohyphomycosis due to a novel dematiaceous fungus, Pleurostoma hongkongense sp. nov., and importance of antifungal susceptibility testing | |
CN111197096A (en) | A method for the study of the toxic effects of jujube nectar on honeybees based on gut microbiota | |
CN103667271B (en) | The primer of detection by quantitative Candida albicans bacterium and probe and application thereof | |
Florek et al. | An analysis of the population of Cryptococcus neoformans strains isolated from animals in Poland, in the years 2015–2019 | |
Ahmed et al. | Gloeostereum cimri, a novel shelf fungus isolated from a human pulmonary cyst | |
Malatji et al. | Gene expression profiles of the small intestine of village chickens from an Ascaridia galli infested environment | |
CN115961070A (en) | A kind of primer-probe combination and kit for detecting aspergillus | |
Fernández et al. | Subcutaneous infection by Graphium basitruncatum in a heart transplant patient | |
Takami et al. | First report of emerging snake fungal disease caused by Ophidiomyces ophiodiicola from Asia in imported captive snakes in Japan | |
CN110106242B (en) | Detection primers and detection methods for the chemotypes of the pathogenic toxin of Fusarium alfalfa root rot | |
Kuibagarov et al. | Moraxella species diversity in infectious bovine keratoconjunctivitis in Nothern Kazakhstan | |
Liu et al. | Generalized tinea corporis caused by Trichophyton verrucosum misdiagnosed as allergic dermatitis and erythema annulare in an adult |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |